Home › Research › What the research found › Every row
Every row of the evidence table
One row per finding: what was tested, which way the result went, and how the study was built. The answer by area, and where the studies disagree, are on the main page.
Every row
Filter
Showing 3 of 382 rows. One row per study per exposure: a study that tested two different things appears twice, once for each.
Scroll the table sideways to see every column.
| Exposure | Question | Direction | Outcome measured | Design | People | Effect size, as the source reported it | Source |
|---|---|---|---|---|---|---|---|
| Hearing loss / hearing aids Hearing and vision | Prevention |
Benefit
whyConfined to people who said the aid actually improved their hearing (HR 0.86); those reporting poor improvement showed nothing (HR 0.98). |
Probable dementia over a mean 6.5 years | cohort study | 61,089 | HR 0.91 (95% CI 0.88-0.94) for hearing aid use; HR 0.86 (0.80-0.93) with effective use |
Cell Reports Medicine
2026 ✓ Peer-reviewed PMID 42127901 |
| Hearing loss / hearing aids Hearing and vision | Prevention |
Harm
whyDirection is for hearing loss. Risk was lower among those using hearing aids (aHR 1.06) than those not (aHR 1.20). The authors note their estimates are smaller than earlier studies'. |
Incident dementia over a mean 8.6 years | cohort study | 573,088 | Hearing loss without hearing aids aHR 1.20 (95% CI 1.13-1.27); with hearing aids aHR 1.06 (1.01-1.10) |
JAMA Otolaryngology-Head & Neck Surgery
2024 ✓ Peer-reviewed PMID 38175662 |
| Vision impairment / cataract surgery Hearing and vision | Prevention |
Harm
whyDirection is for having cataracts or myopia. A Mendelian randomisation analysis supported the cataract-vascular dementia link. |
Incident dementia and brain volume | cohort study | 304,953 | Cataracts HR 1.18 (95% CI 1.07-1.29) for dementia; MR OR 1.92 (1.26-2.92) for vascular dementia |
JAMA Network Open
2024 ✓ Peer-reviewed PMID 39078629 |